Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Neurocrine updates FDA review of indiplon NDAs

Jan. 13, 2006

Ibuprofen may delay or prevent PD

Jan. 13, 2006

IND submission for BEMA LA for moderate to severe pain

Jan. 13, 2006

Hana demonstrates bioequivalence of Zensana ondansetron oral spray

Jan. 13, 2006

Preclinical findings show Miraxion has neuroprotective effects in Parkinson's

Jan. 13, 2006

Cellegesic to be reviewed by FDA Advisory Committee in April

Jan. 13, 2006

Evotec licenses two MAO-B inhibitors from Roche for Alzheimer's disease

Jan. 12, 2006

Novel agents for treating neurological disorders disclosed in recent sanofi-aventis patent

Jan. 12, 2006

FMPD: Lilly's new candidate for psychosis

Jan. 12, 2006

New approval for Emend

Jan. 12, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...